• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

303 例首发单相躁狂症患者的发病率。

Morbidity in 303 first-episode bipolar I disorder patients.

机构信息

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

出版信息

Bipolar Disord. 2010 May;12(3):264-70. doi: 10.1111/j.1399-5618.2010.00812.x.

DOI:10.1111/j.1399-5618.2010.00812.x
PMID:20565433
Abstract

OBJECTIVES

To test the hypotheses that: (i) depressive-dysthymic-dysphoric (D-type) morbidity is more prevalent than manic-hypomanic-psychotic (M-type) morbidity even from first episodes of bipolar I disorder (BPD-I) and despite treatment; (ii) initial presentations predict later morbidity; (iii) morbidity varies internationally; and (iv) early and later morbidity are similar.

METHODS

We followed SCID-based, DSM-IV BPD-I patients (n = 303) systematically and prospectively for two years to estimate the percent of weeks in specific morbid states from first lifetime major episodes.

RESULTS

Total morbidity accounted for 44% of the first two years, and D-type exceeded M-type illnesses by 2.1-fold (30%/14%) among morbidities ranking: mixed states (major + minor) >or= dysthymia >or= mania >or= major depression > hypomania > psychosis. In 164 cases, morbidities at 0.5-2.5 and 2.5-4.5 years were very similar. Depressive or mixed initial episodes predicted a 3.6-fold excess of D-type morbidity, and initial M-type episodes predicted a 7.1-fold excess of M-type morbidity over two years. Morbidity in European (EU) sites was nearly half that in the U.S., and 22% greater overall among men than women. In five comparable studies, illness accounted for 54% of follow-up time, and the ratio of D/M morbidity averaged 3.0.

CONCLUSIONS

In accord with four midcourse studies, morbidity from BPD-I onset, despite treatment by community standards, averaged 44%, was 68% D-type morbidity, and was strongly predicted by first-episode polarity. Lower morbidity in EU than U.S. sites may reflect differences in healthcare or social systems.

摘要

目的

检验以下假设:(i) 即使在双相 I 型障碍 (BPD-I) 的首发发作中并尽管接受了治疗,抑郁障碍-恶劣心境-心境恶劣 (D 型) 发病率也高于躁狂障碍-轻躁狂障碍-精神病性 (M 型) 发病率;(ii) 首发表现可预测后续发病情况;(iii) 发病率存在国际差异;以及 (iv) 早期和晚期发病情况相似。

方法

我们对基于 SCID、DSM-IV 的 BPD-I 患者 (n=303) 进行了系统的前瞻性随访 2 年,以估计首发终生重大发作后特定病态状态的周数比例。

结果

总发病率在头 2 年占 44%,且病态排名为混合状态 (重性+轻度)>=恶劣心境>=躁狂>=重性抑郁>=轻躁狂>=精神病性时,D 型发病率是 M 型的 2.1 倍 (30%/14%)。在 164 例患者中,0.5-2.5 年和 2.5-4.5 年的发病情况非常相似。抑郁或混合性首发发作预示着 D 型发病率增加 3.6 倍,而首发 M 型发作预示着两年内 M 型发病率增加 7.1 倍。欧洲 (EU) 研究地点的发病率接近美国的一半,且男性总体发病率比女性高 22%。在五项可比研究中,疾病占随访时间的 54%,D/M 发病率比平均为 3.0。

结论

与四项中期研究一致,尽管按照社区标准进行了治疗,BPD-I 发病后的发病率平均仍为 44%,D 型发病率为 68%,且受首发发作极性的强烈影响。EU 与美国研究地点的发病率较低可能反映了医疗保健或社会系统的差异。

相似文献

1
Morbidity in 303 first-episode bipolar I disorder patients.303 例首发单相躁狂症患者的发病率。
Bipolar Disord. 2010 May;12(3):264-70. doi: 10.1111/j.1399-5618.2010.00812.x.
2
First-episode types in bipolar disorder: predictive associations with later illness.双相情感障碍的首发类型:与后续疾病的预测性关联。
Acta Psychiatr Scand. 2014 May;129(5):383-92. doi: 10.1111/acps.12204. Epub 2013 Oct 24.
3
Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.具有青春期前和青春期早期双相情感障碍表型的儿童躁狂症的四年前瞻性结局和自然病程。
Arch Gen Psychiatry. 2004 May;61(5):459-67. doi: 10.1001/archpsyc.61.5.459.
4
Onset-age of bipolar disorders at six international sites.双相障碍发病年龄的六个国际研究站点报告。
J Affect Disord. 2010 Feb;121(1-2):143-6. doi: 10.1016/j.jad.2009.05.030. Epub 2009 Jun 28.
5
Concordance of self-rated and observer-rated dysphoric symptoms in mania.躁狂症中自评与他人评定的烦躁症状的一致性。
J Affect Disord. 2009 Apr;114(1-3):294-8. doi: 10.1016/j.jad.2008.06.015. Epub 2008 Aug 6.
6
Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.在法国全国性EPIDEP研究中验证双相谱系:其临床原型的现象学概述及相对患病率
J Affect Disord. 2006 Dec;96(3):197-205. doi: 10.1016/j.jad.2006.05.015. Epub 2006 Jul 7.
7
[Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].[双相情感障碍的临床特殊性:单相躁狂。关于突尼斯一名患者的研究]
Encephale. 2008 Sep;34(4):337-42. doi: 10.1016/j.encep.2007.06.008. Epub 2007 Oct 26.
8
How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity?如何在无自发轻躁狂的重度抑郁患者中最好地识别双相相关亚型:起病年龄标准相对于复发和极性的优越性?
J Affect Disord. 2008 Apr;107(1-3):77-88. doi: 10.1016/j.jad.2007.07.032. Epub 2007 Sep 12.
9
Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder.神经认知测试表现可预测双相情感障碍急性加重导致住院后的功能恢复情况。
Bipolar Disord. 2007 Feb-Mar;9(1-2):93-102. doi: 10.1111/j.1399-5618.2007.00427.x.
10
Is bipolar I disorder heterogeneous?双相I型障碍是异质性的吗?
Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):82-91. doi: 10.1007/s00406-004-0501-6.

引用本文的文献

1
Investigating the Relationship Between Hopelessness, Alexithymia, Mind Wandering, Rumination, and Clinical Features in Patients with Bipolar Disorder.探究双相情感障碍患者的绝望感、述情障碍、思维游荡、沉思与临床特征之间的关系。
Brain Sci. 2025 Jun 2;15(6):596. doi: 10.3390/brainsci15060596.
2
Aripiprazole/Sertraline Combination: Clinical and Cost-Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)-Protocol for a Nested Qualitative Study.阿立哌唑/舍曲林联合治疗与喹硫平治疗双相抑郁的临床和成本效益比较(ASCEnD 试验)-嵌套定性研究方案。
Health Expect. 2024 Oct;27(5):e70018. doi: 10.1111/hex.70018.
3
Understanding of Depressive Symptomatology across Major Depressive Disorder and Bipolar Disorder: A Network Analysis.
理解重度抑郁症和双相情感障碍的抑郁症状学:网络分析。
Medicina (Kaunas). 2023 Dec 24;60(1):32. doi: 10.3390/medicina60010032.
4
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies.双相抑郁的药物治疗:观察性研究综述
Pharmaceuticals (Basel). 2023 Jan 25;16(2):182. doi: 10.3390/ph16020182.
5
Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder.文拉法辛与安非他酮治疗双相II型障碍患者抑郁发作疗效的比较。
J Family Med Prim Care. 2023 Mar;12(3):440-445. doi: 10.4103/jfmpc.jfmpc_1258_22. Epub 2023 Mar 17.
6
Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review.奥氮平与沙米多芬联合用于成人精神分裂症和双相 I 型障碍的治疗:一项叙述性综述。
Health Psychol Res. 2022 Apr 25;10(3):34224. doi: 10.52965/001c.34224. eCollection 2022.
7
Differences in Demographic and Clinical Characteristics of Patients With Depressive vs. Manic First Episode of Bipolar Disorder.双相情感障碍抑郁首发与躁狂首发患者的人口统计学和临床特征差异
Front Psychiatry. 2021 Feb 4;12:616415. doi: 10.3389/fpsyt.2021.616415. eCollection 2021.
8
Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.多剂量氯胺酮增效治疗对治疗抵抗性双相抑郁患者治疗抵抗性抑郁症状的短暂影响 - 一项开放标签的三周先导研究。
Brain Behav. 2020 Aug;10(8):e01674. doi: 10.1002/brb3.1674. Epub 2020 Jul 3.
9
Effectiveness of Sleep Deprivation in Treating Acute Bipolar Depression as Augmentation Strategy: A Systematic Review and Meta-Analysis.睡眠剥夺作为增效策略治疗急性双相抑郁的有效性:一项系统评价和荟萃分析。
Front Psychiatry. 2020 Feb 25;11:70. doi: 10.3389/fpsyt.2020.00070. eCollection 2020.
10
Validity and characteristics of patient-evaluated adherence to medication via smartphones in patients with bipolar disorder: exploratory reanalyses on pooled data from the MONARCA I and II trials.双相情感障碍患者通过智能手机评估的药物依从性的有效性和特征:对MONARCA I和II试验汇总数据的探索性再分析
Evid Based Ment Health. 2020 Feb;23(1):2-7. doi: 10.1136/ebmental-2019-300106.